These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 6141053

  • 1. Concentration-effect and time-effect relationships of carteolol.
    Ishizaki T, Ohnishi A, Sasaki T, Chiba K, Suganuma T, Kushida K.
    Eur J Clin Pharmacol; 1983; 25(6):749-57. PubMed ID: 6141053
    [Abstract] [Full Text] [Related]

  • 2. Beta-blocking effect of single oral doses of carteolol.
    Stoll RW, Cavanaugh JH, MacLeod CM.
    Clin Pharmacol Ther; 1981 Nov; 30(5):605-10. PubMed ID: 7297020
    [Abstract] [Full Text] [Related]

  • 3. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G, Veidt J, Mikludy R, Kaltenbach M.
    Arzneimittelforschung; 1983 Nov; 33(2a):313-7. PubMed ID: 6682323
    [Abstract] [Full Text] [Related]

  • 4. Effects of long use of a beta-blocker, carteolol, on exercise hemodynamics in hypertensives.
    Katori R, Tashi M, Ohno M, Oogai T, Morishita M, Morii S.
    Jpn Circ J; 1985 Jan; 49(1):52-60. PubMed ID: 3968862
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hemodynamic studies at rest and under stress in patients with coronary heart disease after administration of carteolol].
    Saborowski F, Dundalek E, Griebenow R, Sy M.
    Arzneimittelforschung; 1983 Jan; 33(2a):310-2. PubMed ID: 6682322
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of in vivo partial beta 1/beta 2-agonist activity: a dose-ranging study with carteolol.
    Wheeldon NM, McDevitt DG, Lipworth BJ.
    Br J Clin Pharmacol; 1992 Apr; 33(4):411-6. PubMed ID: 1349493
    [Abstract] [Full Text] [Related]

  • 8. [Pharmacodynamics of carteolol].
    Odenthal KP.
    Arzneimittelforschung; 1983 Apr; 33(2a):281-5. PubMed ID: 6132609
    [Abstract] [Full Text] [Related]

  • 9. Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
    Brazier DJ, Smith SE.
    Br J Ophthalmol; 1988 Feb; 72(2):101-3. PubMed ID: 3349009
    [Abstract] [Full Text] [Related]

  • 10. Dose difference in beta-adrenergic blockers with intrinsic sympathomimetic action to block beta-adrenoceptors and induce sympathomimetic action.
    Takayanagi I, Ogishima M, Koike K, Hisayama T, Hayashida M, Fujii M.
    Gen Pharmacol; 1989 Feb; 20(4):417-9. PubMed ID: 2568966
    [Abstract] [Full Text] [Related]

  • 11. Effects of the non-selective beta-adrenoceptor blocking agent, carteolol, on platelet function, blood coagulation and viscosity.
    Small M, Douglas JT, Aherne GW, Orr M, Lowe GD, Forbes CD, Prentice CR.
    Thromb Res; 1982 Feb 15; 25(4):351-60. PubMed ID: 6122288
    [Abstract] [Full Text] [Related]

  • 12. A study on the cardiodepressant action of a beta-blocking agent carteolol in heart-lung preparation of the dog.
    Ono H, O'Hara N.
    Jpn Circ J; 1984 Sep 15; 48(9):1030-44. PubMed ID: 6481940
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of the effects of carteolol and metipranolol eyedrops on the ventilatory and cardiovascular functions in asthmatics].
    Hugues FC, Le Jeunne C, Munera Y, Dufier JL.
    J Fr Ophtalmol; 1987 Sep 15; 10(8-9):485-90. PubMed ID: 2892874
    [Abstract] [Full Text] [Related]

  • 14. Effect of carteolol, indenolol and metoprolol on the thyroid hormone of hyperthyroid patients.
    Yamamoto M, Sakurada T, Yoshida K, Kaise K, Kaise N, Fukazawa H, Suzuki M, Nomura T, Itagaki Y, Saito S.
    Tohoku J Exp Med; 1985 Aug 15; 146(4):385-90. PubMed ID: 2866611
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of oral befunolol on heart rate and systolic blood pressure during submaximal exercise in man.
    Miki N, Furusho Y, Itaya K, Midorikawa K, Kumagai E, Terasawa M, Ihara S, Matoba T, Toshima H.
    Jpn Circ J; 1980 Oct 15; 44(10):783-93. PubMed ID: 6107392
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of carteolol on silent myocardial ischemia, variability in heart rate, and the pain-modulating system.
    Takase B, Hikita H, Uehata A, Satomura K, Kurita A, Nakamura H.
    Am Heart J; 1997 Nov 15; 134(5 Pt 1):945-54. PubMed ID: 9398108
    [Abstract] [Full Text] [Related]

  • 20. Human pharmacokinetic and pharmacodynamic studies on Ro31-1118, a new beta-adrenoceptor antagonist.
    O'Connor PC, Arnold JM, Brown AN, Francis RJ, Finch MB, Galloway DB, Harron DW, McDevitt DG, Shanks RG.
    Br J Clin Pharmacol; 1985 Mar 15; 19(3):319-27. PubMed ID: 2859047
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.